For patients with tough-to-treat cancers, treatment approaches have advanced significantly over the past several decades. Scientists have made significant progress in understanding cancer biology. In this episode, sponsored by AbbVie, we explore how the discovery of biomarkers – the biological “signatures” for certain cancers – have helped create a paradigm shift in how we treat cancer by focusing on precision medicine approaches to target specific tumors. Not intended for UK audiences.

To learn more about AbbVie’s research in oncology, visit: https://www.abbvie.com/science/areas-of-focus/oncology.html.

Medication access goes beyond the ability to obtain the medication prescribed – it's also about the logistics: developing, manufacturing and delivering a medicine. This episode, sponsored by AbbVie, explores how teams are rethinking operations and manufacturing to prioritize the most important piece of the puzzle: the patient. Behind every package that reaches a patient lies remarkable science, dedication, and ingenuity, ensuring that care makes it all the way to those who need it most. Not intended for UK audiences.

To find out more about AbbVie’s operations and manufacturing capabilities, visit: https://www.abbvie.com/who-we-are/our-stories/how-abbvies-integrated-operations-help-prevent-drug-shortages.html

For many patients, navigating the health care system can be painstakingly difficult. But a conversation with an advocate can change everything. In this episode, sponsored by AbbVie, we follow the patient journey through the complexities of the health care system. Along the way, we meet people behind AbbVie’s patient support teams, who aim to help patients feel seen, heard, and empowered. Not intended for UK audiences.

To find out more about AbbVie patient support, visit: www.abbvie.com/patients/patient-support.html

Is it possible to deliver medicine to the brain when the brain won’t let it in? The blood-brain barrier is the brain’s personal fortress, protecting it from potentially dangerous pathogens. But that same barrier can also prevent the delivery of medicines. In this episode, sponsored by AbbVie, we meet the scientists exploring the use of shuttle technology to navigate the blood-brain barrier and potentially address conditions of the brain. It’s a story of scientific persistence and the new approaches that might develop when you stop trying to knock down the door and learn how to unlock it. Not intended for UK audiences.

To learn about AbbVie’s approach to neuroscience research, visit: https://www.abbvie.com/science/areas-of-focus/neuroscience.html

Our health and well-being impact every element of our lives. For patients with some of the most difficult-to-treat medical conditions, a cure is what they’re hoping for. How can we accelerate drug development to spur progress and turn bold ideas into real breakthroughs? We launch our journey into The Persistence Lab, a podcast sponsored by AbbVie, with a look at how the company is empowering scientists to boldly rethink what it means to cure disease and accelerate care for patients. Not intended for UK audiences.

To learn more about AbbVie’s approach to scientific discovery, visit: https://www.abbvie.com/science/our-people/community-of-science.html

The Persistence Lab, a podcast from AbbVie, invites you to step into the lives of the people who wake up every day determined to solve some of the toughest challenges in medicine and health care. Here, breakthroughs aren’t single moments – they’re the result of questions pursued, experiments refined, and teams who push forward even when the path gets complicated. This is where science meets humanity, and where persistence turns possibilities into real impact for patients. Not intended for UK audiences.